-

06:30:01 PM

BSX Stock News

BSX - Boston Scientific Corp.

10/03/22 9:30 AM

NYSE : BSX

Boston Scientific Announces Conference Call Discussing Third Quarter 2022 Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2022 on Wednesday, October 26, 2022 at 8:00 a.m. EDT. The call will be hosted

RHEA-AI

neutral

09/17/22 11:21 AM

NYSE : BSX

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL(TM) Cerebral Protection System

Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL(TM) Cerebral Protection System, which is designed

RHEA-AI

neutral

09/06/22 6:55 AM

NYSE : BSX

fda approval

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX(TM) LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand

RHEA-AI

neutral

08/16/22 2:00 PM

NYSE : BSX

conferences

Boston Scientific Announces Upcoming Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor events.On Wednesday, September 7, 2022, Mike Mahoney, chairman and chief executive officer, and Lauren Tengler, vice president, Investor Relations, will

RHEA-AI

neutral

08/15/22 7:00 AM

NYSE : BSX

acquisition

Boston Scientific Announces Acquisition of Obsidio, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company

RHEA-AI

neutral

08/01/22 7:00 AM

NYSE : NVRO, BSX

Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations

Nevro Corp. (NYSE: NVRO) and Boston Scientific Corp. (NYSE: BSX) announced today that they have reached a settlement in their ongoing intellectual property

RHEA-AI

neutral

07/27/22 6:30 AM

NYSE : BSX

Boston Scientific Announces Results for Second Quarter 2022

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.244 billion during the second quarter of 2022, growing 5.4 percent on a reported basis, 9.6 percent on an operational 1 basis and 6.6 percent on an organic 2 basis, all compared to

RHEA-AI

neutral

06/29/22 9:30 AM

NYSE : BSX

Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ending June 30, 2022 on Wednesday, July 27, 2022 at 8:00 a.m. EDT. The call will be hosted by

RHEA-AI

neutral

06/15/22 7:00 AM

NYSE : BSX

Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly

RHEA-AI

neutral

05/02/22 9:30 AM

NYSE : BSX

conferences

Boston Scientific to Participate in Bank of America Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) will participate in Bank of America's Global Healthcare Conference on Thursday, May 12.Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 Next

BSX Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.bostonscientific.com
CeoMichael Mahoney
Security nameBoston Scientific Corp.
Issue typecs
SectorManufacturing
Sic code3841
Employees2021
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address300 Boston Scientific Way
StateMassachusetts
CityMarlborough
Zip01752-1291
CountryUS
Phone15086834000

About Boston Scientific Corp.

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, The company advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.